In this interview, two experts in the field of acute myeloid leukaemia (AML), Jean-Baptiste Micol, University of Paris-Saclay, France, and Thomas Cluzeau, University Hospital of Nice, France, share their views and debate the current landscape of real-world data in AML research and treatment.
EMJ Hematology 9 [Supplement 5] . 2021
November 2021
In this issue
Latest articles
All articles![](https://www.emjreviews.com/wp-content/uploads/2024/04/Niamh-OConnell-Thumbnail-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/03/Pier-Mannucci-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2024/03/Immunoglobin-D-Multiple-Myeloma-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2024/02/Coexistence-of-Sickle-Cell-Thalassaemia-with-Overlapping-Syndrome-940x564.png)